Physician
Obstetrics & Gynecology
Dr. Matthew P. Boente, MD
Matthew P. Boente, MD works in the field of Obstetrics & Gynecology. He went to medical school at Rush Medical College. He received 4 awards: "Meaningful Use Stage 1 Certification", "Top MD", "Fellow (FACS)" and "Fellow (FACOG)". Dr. Matthew P. Boente is a published physician. He has 37 publications published. The most current publication "Surgery for gynecologic malignancies." Matthew P. Boente, MD accepts Medicare.
Publications
- Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal Cancers: An NRG Oncology/GOG study.
- Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study.
- A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal Carcinoma: MC0261.
- A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial Cancer.
- A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian Carcinoma.
- Widespread lymph node metastases in a young woman with FIGO stage IA1 squamous Cervical cancer.
- Utility and limitations of abdominal radiotherapy in the management of endometrial Carcinomas.
- Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial Carcinoma of the ovary.
- Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
- A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent Cervical cancer.
- Hysteroscopy and cytology in endometrial Cancer.
- A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy.
- A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian Cancer.
- Preoperative detection of peripherally circulating Cancer cells and its prognostic significance in ovarian Cancer.
- The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant Ovarian epithelial cells.
- The use of tumor markers in the management of patients with gynecologic Carcinomas.
- Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
- Regulation of growth of normal ovarian epithelial cells and ovarian Cancer cell lines by transforming growth factor-beta.
- Growth regulation and transformation of Ovarian epithelium.
- Current status of staging laparotomy in colorectal and ovarian Cancer.
- The management of early ovarian Cancer.
- Gynecologic Cancers.
- The role of surgery in the management of recurrent gynecologic Cancer.
- Gynecological Cancers.
- Surgery for gynecologic malignancies.
- Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cells.
- Early ovarian Cancer: a review of its genetic and biologic factors, detection, and treatment.
- Ploidy analysis of epithelial ovarian Cancers using image cytometry.
- Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapy.
- Prognostic factors and long-term survival in endometrial adenoCarcinoma with cervical involvement.
- Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial Cancer.
- Recurrence patterns and complications in endometrial adenoCarcinoma with cervical involvement.
- Suppression of diacylglycerol levels by antibodies reactive with the c-erbB-2 (HER-2/neu) gene product p185c-erbB-2 in breast and ovarian Cancer cell lines.
- Recurrent ovarian Cancer. Effective radiotherapeutic palliation after chemotherapy failure.
- Disaggregation and invasion of ovarian Carcinoma ascites spheroids.
- Feasibility and morbidity of using saline filled tissue expanders to reduce radiation-induced bowel injury in patients with gynecologic malignancies.
Schools
Rush Medical College Of Rush University
Procedures Preformed
- Abdominal Hysterectomy With Robotic Assistance
- Colporrhaphy
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- View All
Conditions Treated
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Choice Plus POS
- Navigate POS
- Options PPO
Awards
- Meaningful Use Stage 1 Certification
- Top MD
- Fellow (FACS)
- Fellow (FACOG)
Education
-
Rush University Medical Center
-
Rush Medical College
Hospital
-
Abbott Northwestern Hospital
Drug Facts
| NPI NUMBER |
|
1336116391 |
| NPPES Provider LastName |
|
BOENTE |
| NPPES Provider FirstName |
|
MATTHEW |
| NPPES Provider ZIPCode |
|
554352281 |
| NPPES Provider State |
|
MN |
| Specialty Description |
|
Gynecological/Oncology |
| Total Claim Count |
|
643.0 |
| Distinct Opioid Count |
|
2.0 |
| Opioid Claim Count |
|
39.0 |
| Percent Opioid Claims |
|
6.07 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1336116391 |
| Last Name Of The Provider |
BOENTE |
| First Name Of The Provider |
MATTHEW |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.
This doctor has more publications